carbamazepine has been researched along with Facial Hemiatrophy in 2 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
Facial Hemiatrophy: A syndrome characterized by slowly progressive unilateral atrophy of facial subcutaneous fat, muscle tissue, skin, cartilage, and bone. The condition typically progresses over a period of 2-10 years and then stabilizes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mrabet Khiari, H | 1 |
| Masmoudi, S | 1 |
| Mrabet, A | 1 |
| Madruga Dias, J | 1 |
| Costa, MM | 1 |
| Pereira da Silva, JA | 1 |
| Viana de Queiroz, M | 1 |
2 other studies available for carbamazepine and Facial Hemiatrophy
| Article | Year |
|---|---|
[Association of Parry-Romberg syndrome and paroxymal kinesigenic dyskinesia].
Topics: Adult; Anticonvulsants; Carbamazepine; Chorea; Electroencephalography; Electromyography; Facial Hemi | 2009 |
Parry-Romberg syndrome in an 11-year-old female with neurological manifestations without brain imaging abnormalities.
Topics: Anticonvulsants; Brain; Carbamazepine; Child; Epilepsy; Facial Hemiatrophy; Female; Humans; Magnetic | 2012 |